Page last updated: 2024-10-18

dalteparin and Female Genital Diseases

dalteparin has been researched along with Female Genital Diseases in 2 studies

Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)

Research Excerpts

ExcerptRelevanceReference
"No deep venous thrombosis and no pulmonary embolism were observed."1.29[General perioperative prevention of thromboembolism in gynecology with low-molecular weight heparin: clinical experiences with enoxaparin over 7 years]. ( Slunsky, R, 1995)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Slunsky, R1
Ward, B1
Pradhan, S1

Trials

1 trial available for dalteparin and Female Genital Diseases

ArticleYear
Comparison of low molecular weight heparin (Fragmin) with sodium heparin for prophylaxis against postoperative thrombosis in women undergoing major gynaecological surgery.
    The Australian & New Zealand journal of obstetrics & gynaecology, 1998, Volume: 38, Issue:1

    Topics: Anticoagulants; Dalteparin; Female; Genital Diseases, Female; Heparin; Humans; Injections, Subcutane

1998

Other Studies

1 other study available for dalteparin and Female Genital Diseases

ArticleYear
[General perioperative prevention of thromboembolism in gynecology with low-molecular weight heparin: clinical experiences with enoxaparin over 7 years].
    Zentralblatt fur Gynakologie, 1995, Volume: 117, Issue:11

    Topics: Adult; Aged; Anticoagulants; Blood Coagulation Tests; Combined Modality Therapy; Dose-Response Relat

1995